Kendra K Maass
Overview
Explore the profile of Kendra K Maass including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
320
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ghasemi D, Okonechnikov K, Rademacher A, Tirier S, Maass K, Schumacher H, et al.
Nat Commun
. 2024 Oct;
15(1):8597.
PMID: 39366943
No abstract available.
2.
Genard G, Tirinato L, Pagliari F, Da Silva J, Giammona A, Alquraish F, et al.
J Extracell Biol
. 2024 Sep;
3(9):e162.
PMID: 39257626
Despite increasing knowledge about small extracellular vesicle (sEV) composition and functions in cell-cell communication, the mechanism behind their biogenesis remains unclear. Here, we reveal for the first time that sEV...
3.
Kocher D, Cao L, Guiho R, Langhammer M, Lai Y, Becker P, et al.
J Neurooncol
. 2024 Apr;
168(2):317-332.
PMID: 38630384
Introduction: Patients with pediatric low-grade gliomas (pLGGs), the most common primary brain tumors in children, can often benefit from MAPK inhibitor (MAPKi) treatment. However, rapid tumor regrowth, also referred to...
4.
Ghasemi D, Okonechnikov K, Rademacher A, Tirier S, Maass K, Schumacher H, et al.
Nat Commun
. 2024 Jan;
15(1):269.
PMID: 38191550
Medulloblastomas with extensive nodularity are cerebellar tumors characterized by two distinct compartments and variable disease progression. The mechanisms governing the balance between proliferation and differentiation in MBEN remain poorly understood....
5.
Rautajoki K, Jaatinen S, Hartewig A, Tiihonen A, Annala M, Salonen I, et al.
Acta Neuropathol Commun
. 2023 Nov;
11(1):176.
PMID: 37932833
As the progression of low-grade diffuse astrocytomas into grade 4 tumors significantly impacts patient prognosis, a better understanding of this process is of paramount importance for improved patient care. In...
6.
Rautajoki K, Jaatinen S, Tiihonen A, Annala M, Vuorinen E, Kivinen A, et al.
Sci Rep
. 2022 Aug;
12(1):14083.
PMID: 35982066
Oligodendrogliomas are typically associated with the most favorable prognosis among diffuse gliomas. However, many of the tumors progress, eventually leading to patient death. To characterize the changes associated with oligodendroglioma...
7.
Liu A, Smith K, Kumar R, Paul L, Bihannic L, Lin T, et al.
Cancer Cell
. 2021 Oct;
39(11):1519-1530.e4.
PMID: 34678152
Nearly one-third of children with medulloblastoma, a malignant embryonal tumor of the cerebellum, succumb to their disease. Conventional response monitoring by imaging and cerebrospinal fluid (CSF) cytology remains challenging, and...
8.
Sievers P, Henneken S, Blume C, Sill M, Schrimpf D, Stichel D, et al.
Acta Neuropathol
. 2021 Aug;
142(5):827-839.
PMID: 34355256
Ependymomas encompass a heterogeneous group of central nervous system (CNS) neoplasms that occur along the entire neuroaxis. In recent years, extensive (epi-)genomic profiling efforts have identified several molecular groups of...
9.
Maass K, Schad P, Finster A, Puranachot P, Rosing F, Wedig T, et al.
Cancers (Basel)
. 2021 Jul;
13(12).
PMID: 34203921
Liquid biopsies hold great promise for the management of cancer. Reliable liquid biopsy data depend on stable and reproducible pre-analytical protocols that comply with quality measures, irrespective of the sampling...
10.
Zheng T, Ghasemi D, Okonechnikov K, Korshunov A, Sill M, Maass K, et al.
Cancer Discov
. 2021 Apr;
11(9):2230-2247.
PMID: 33879448
Molecular groups of supratentorial ependymomas comprise tumors with or -involving fusions and fusion-negative subependymoma. However, occasionally supratentorial ependymomas cannot be readily assigned to any of these groups due to lack...